Skip to content
Home/Companies/Biotech/Provepharm
PR

Provepharm

Biotech·France·Active·8yr hold

Provepharm is a healthcare company, headquartered in France.

Entry
2018
Hold
8yr
Status
Active
Est. EV
–

Who owns Provepharm?

Provepharm is currently owned by ARCHIMED through MED II (2017 vintage), since 2018. Across its history, Provepharm has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

ARCHIMED
Most recent investor
ARCHIMED
MED II · 2017 · Buyout
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods

Active
Currently held by ARCHIMED since 2018.
SOFIPACA - Groupe Crédit Agricole
SOFIPACA - Groupe Crédit AgricoleExited 2018
2011 · 2018 · SOFIPACA Evergreen · 1991 · Growth
Secondary · to
MOIC
–
ARCHIMED
ARCHIMEDActive
2018 · present · MED II · 2017 · Buyout
MOIC
–

More from MED II

Other portfolio companies in the same fund.

Clean Biologics
Active
BiotechFrance· 2018
Soest Medical Group
Active
MedTechThe Netherlands· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings